Genomic & Biopharma NewsPhilips announces launch of global movement to raise awareness for COPD
Ahead of World COPD Day on November 15, Royal Philips, a leader in health technology, today announced the launch of a global movement to raise awareness for chronic obstructive pulmonary disease (COPD).
|News Medical Life Sciences, 2017-11-17 13:46:00|
Pelican Newspaper: Gene profiling at Ocean Ridge Biosciences to unlock mysteries of the human body
Identifying the markers for pancreatic cancer may have happened here in a 5,400 square foot facility where scientists routinely practice next generation RNA profiling and biomarker discovery. Please read the PDF for more details
|ORB Company News, 2016-11-25 18:55:37|
New dye could be used to observe electrical activity of neurons in the brain
Keele University researchers have designed a new dye that can be used to observe the electrical activity of neurons in the brain and could lead to finding a new and more efficient way of treating neurological diseases.
|News Medical Life Sciences, 2017-11-17 13:43:12|
NONCODEV5 – a comprehensive annotation database for long non-coding RNAs
NONCODE is a systematic database that is dedicated to presenting the most complete collection and annotation of non-coding RNAs (ncRNAs), especially long non-coding RNAs (lncRNAs). Since NONCODE 2016 was released two years ago, the amount of novel identified ncRNAs has been enlarged by the reduced cost of next-generation sequencing, which has produced an explosion of ...
|lncRNA Research and Industry News, 2017-11-17 13:21:39|
Nanostructures research may have big impact on cancer diagnosis
Less than a third of scientific researchers, and only 3 per cent of scientific Nobel Prize winners, are women. Danielle McRae is hoping to make a dent in those numbers. The third-year Physical Chemistry PhD student was one of five Canadian researchers recently honoured through the L’Oréal-UNESCO For Women in Science program, presented with the ...
|Exosome RNA Research & Industry News, 2017-11-17 13:12:52|
FiercePharmaAsia—Pfizer’s China JV, Otsuka-Proteus’ digital pill, Astellas’ charity donations
Pfizer sold all of its 49% stake in a Chinese joint venture with Zhejiang Hisun Pharma, the FDA approved the U.S.’s first digital medicine by Otsuka and Proteus, Astellas joined a long list of industry big names under investigation for their copay charity donations, and more.
|Fierce Pharma, 2017-11-17 13:05:45|
Building on Cures Act, FDA lays out cell therapy fast track in regenerative medicine framework
The FDA has created a policy framework for cellular therapies and other regenerative medicines by releasing two draft and two final guidance documents. Publication of the texts builds on the 21st Century Cures Act by setting criteria for the new Regenerative Medicine Advanced Therapy designation and outlining the benefits of the regulatory status.
|Fierce Biotech, 2017-11-17 13:05:40|
CMU Software Assembles RNA Transcripts More Accurately
Method should help scientists understand regulation of gene expression Computational biologists at Carnegie Mellon University have developed a more accurate computational method for reconstructing the full-length nucleotide sequences of the RNA products in cells, called transcripts, that transform information from a gene into proteins or other gene products. Their software, called Scallop, will help scientists ...
|Transcriptome Research & Industry News, 2017-11-17 12:42:43|
COPD survey reveals gaps in care
A survey of 500 people across Britain diagnosed with chronic obstructive pulmonary disease (COPD) has revealed that almost a third (31 percent) feel their treatment is not adequately controlling their condition.
|PharmaTimes, 2017-11-17 11:39:49|
ORB relocates to Deerfield Beach and celebrates grand opening of new facility with local researchers
After 8 years of operation in Palm Beach Gardens, Ocean Ridge Biosciences (ORB) has recently relocated to a 5,394 sq. ft. facility in Deerfield Beach, Florida. The new facility provides several improvements which will enable ORB to provide improved and expanded services to academic and corporate clients. These include:
|ORB Company Blog, 2016-11-21 19:26:55|
FDA widens scope of Pfizer’s Sutent in kidney cancer
The US Food and Drug Administration has cleared Pfizer’s Sutent for adjuvant treatment of adults at a high risk of their kidney cancer returning after a kidney has been removed.
|PharmaTimes, 2017-11-17 11:32:42|